Jianguo Zhao
Tianjin Key Laboratory Of Human Development And Reproductive Regulation
Tianjin, 300110, China
Tianjin, 300110, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
HPD is an RNA-Binding Protein Sustaining Ovarian Cancer Cell Glycolysis, Tumor Growth, and Drug Resistance.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 03, 2025
Validation of guiding needle placement using registered ultrasound imaging for gynecologic brachytherapy in a simulated pelvic Phantom.
Journal: Scientific reports
Published: March 01, 2025
Improved practical value of the FIGO 2023 staging system in evaluating prognosis of early stages endometrial carcinoma.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: November 20, 2024
Impact of the microcystic, elongated, and fragmented invasion pattern on prognosis in endometrial carcinoma: a comprehensive meta-analysis.
Journal: Frontiers in oncology
Published: November 13, 2024
Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer.
Journal: Expert opinion on therapeutic targets
Published: August 12, 2023
HPV16 E7 oncoprotein test as a triage strategy for HPV16-positive women in cervical cancer screening: long-term follow-up outcome.
Journal: Frontiers in oncology
Published: May 22, 2023
A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study.
Journal: Journal of gynecologic oncology
Published: October 30, 2022
Preoperative and intraoperative assessment of myometrial invasion in patients with FIGO stage I non-endometrioid endometrial carcinoma-a large-scale, multi-center, and retrospective study.
Journal: Diagnostic pathology
Published: October 22, 2022
Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo.
Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo.
Journal: Molecules (Basel, Switzerland)
Published: October 13, 2022
PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1.
Journal: MedComm
Published: October 08, 2022
Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway.
Journal: Archives of biochemistry and biophysics
Published: July 12, 2022
Last Updated: 09/26/2026